lansoprazole 30 MG Disintegrating Oral Tablet [Prevacid]

Known as: Prevacid SoluTab 30 MG Delayed Release Disintegrating Oral Tablet, Prevacid 30 MG Delayed Release Disintegrating Oral Tablet, LANSOPRAZOLE 30 mg ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE [Prevacid] 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2006-2012
0120062012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
  • 2012
-----------------------------DRUG INTERACTIONS--------------------------­ • Atazanavir: Do not co-administer with atazanavir. (7… (More)
  • table 2
  • table 3
  • table 4
  • table 5
  • table 6
Is this relevant?
2011
2011
PURPOSE The quality attributes of extemporaneous delayed-release liquid formulations of lansoprazole for oral administration were… (More)
Is this relevant?
2010
2010
  • 2010
---------------------------RECENT MAJOR CHANGES--------------------------Dosage and Administration: Important Administration… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2006
2006
BACKGROUND Orally and intravenously administered proton pump inhibitors have been shown to reduce rebleeding rates, surgery and… (More)
Is this relevant?